Online citations, reference lists, and bibliographies.

Nanoparticles: Cellular Uptake And Cytotoxicity.

Isaac M. Adjei, B. Sharma, V. Labhasetwar
Published 2014 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Understanding the interactions of nanoparticles (NPs) with cells and how these interactions influence their cellular uptake is essential to exploring the biomedical applications of NPs, particularly for drug delivery. Various factors, whether differences in physical properties of NPs or variations in cell-membrane characteristics, influence NP-cell interactions and uptake processes. NP-cell membrane interactions may also influence intracellular trafficking of NPs, their sorting into different intracellular compartments, cellular retention, and hence the efficacy of encapsulated therapeutics. A crucial consideration is whether such interactions might cause any toxicity, starting with how NPs interact in transit with the biological environment prior to their interactions with targeted cells and tissues. Understanding the effects of various NP characteristics on cellular and biological processes could help in designing NPs that are efficient but also nontoxic.
This paper references
10.1042/BJ20031253
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
10.1016/j.biomaterials.2009.09.060
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.
Xinglu Huang (2010)
10.1038/nnano.2008.30
Nanoparticle-mediated cellular response is size-dependent.
W. Jiang (2008)
10.1021/MA035407D
Modular norbornene derivatives for the preparation of well-defined amphiphilic polymers: Study of the lipid membrane disruption activities
M. F. Ilker (2004)
10.1016/j.ejpb.2012.05.014
Targeting drugs to mitochondria.
A. Heller (2012)
10.1073/pnas.1534635100
Single metallic nanoparticle imaging for protein detection in cells
L. Cognet (2003)
10.1016/j.ceb.2013.02.018
The journey of the organelle: teamwork and regulation in intracellular transport.
Kari Barlan (2013)
10.1038/nature01451
Regulated portals of entry into the cell
S. Conner (2003)
10.1016/j.taap.2011.11.010
Nanotoxicology and in vitro studies: the need of the hour.
Sumit Arora (2012)
10.1074/jbc.R900012200
The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine*
A. Pratt (2009)
10.1073/pnas.1216893110
Particle shape enhances specificity of antibody-displaying nanoparticles
Sutapa Barua (2013)
10.1016/j.canlet.2013.03.011
Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy.
Blanka Sharma (2013)
10.1021/bc700448h
Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles.
E. Kwon (2008)
10.1074/JBC.M209548200
Cell-penetrating Peptides
Jean Philippe Richard (2003)
10.1016/j.jconrel.2011.10.031
Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.
A. J. Kim (2012)
10.1016/J.IJPHARM.2007.04.036
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.
Susumu Nagayama (2007)
10.1016/J.CEB.2004.06.001
Cargo recognition during clathrin-mediated endocytosis: a team effort.
A. Sorkin (2004)
10.1152/physrev.00002.2012
Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis.
M. Bohdanowicz (2013)
10.1021/nn800330a
Uptake and intracellular fate of surface-modified gold nanoparticles.
P. Nativo (2008)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1002/JEMT.10089
Structure and function of endothelial caveolae
R. Stan (2002)
10.1016/S0939-6411(02)00081-4
Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis.
A. Gessner (2002)
10.1517/17425247.2011.559223
Recent advances of siRNA delivery by nanoparticles
Xu-dong Yuan (2011)
10.1021/BC049775D
Transferrin-mediated gold nanoparticle cellular uptake.
P. Yang (2005)
10.3109/17435390.2011.604442
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
K. Greish (2012)
10.1021/nn201624c
Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Eunkeu Oh (2011)
10.1016/j.biomaterials.2012.07.054
Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities.
R. Shrestha (2012)
10.2217/nnm.13.70
Heterogeneity in nanoparticles influences biodistribution and targeting.
Isaac M. Adjei (2014)
10.1083/jcb.200302028
Caveolae/raft-dependent endocytosis
I. Nabi (2003)
10.1021/mp800032f
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
M. Dobrovolskaia (2008)
10.2174/1567201043334768
Targeting intracellular targets.
J. Panyam (2004)
10.1002/smll.200901158
Effect of surface properties on nanoparticle-cell interactions.
Ayush Verma (2010)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1021/MP034002C
Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles.
J. Panyam (2004)
10.1021/NL070363Y
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.
B. Chithrani (2007)
10.1016/J.YMTHE.2005.03.038
Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.
J. Rejman (2005)
10.2174/1389203033487306
TAT peptide internalization: seeking the mechanism of entry.
E. Vivès (2003)
10.1021/mp9000662
Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.
Chiranjeevi Peetla (2009)
10.1517/17425247.2011.547934
Cellular interactions of therapeutically delivered nanoparticles
A. Kumari (2011)
10.1038/nmat2202
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles.
Ayush Verma (2008)
10.1016/j.sbi.2009.06.003
Sialic acids as regulators of molecular and cellular interactions
R. Schauer (2009)
10.1007/s11095-013-1111-7
Mitochondrial Delivery of Doxorubicin by Triphenylphosphonium-Functionalized Hyperbranched Nanocarriers Results in Rapid and Severe Cytotoxicity
T. Theodossiou (2013)
10.1021/nn2043803
Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.
T. Yu (2012)
10.1016/J.CBPA.2003.08.007
In vivo near-infrared fluorescence imaging.
J. V. Frangioni (2003)
10.1016/J.JCONREL.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
10.1016/S0001-8686(02)00071-4
Langmuir monolayers to study interactions at model membrane surfaces.
G. Brezesinski (2003)
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.1016/j.cub.2011.07.035
Organelle Transport: Mitochondria Hitch a Ride on Dynamic Microtubules
Liza A Pon (2011)
10.1016/S0955-0674(02)00351-4
Plasma membrane microdomains.
F. Maxfield (2002)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
10.1371/journal.pone.0062018
Defining the Subcellular Interface of Nanoparticles by Live-Cell Imaging
P. Hemmerich (2013)
10.1002/smll.201100001
Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.
F. Zhao (2011)
10.1073/pnas.0807296105
Nanoparticle-induced surface reconstruction of phospholipid membranes
B. Wang (2008)
10.1016/j.biomaterials.2011.01.008
Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy.
R. Mejías (2011)
10.1146/annurev.biochem.78.081307.110540
Mechanisms of endocytosis.
G. Doherty (2009)
10.2217/17435889.3.1.125
Electron tomography in nanoparticle imaging and analysis.
Jeffrey S. Lengyel (2008)
10.1155/2013/314091
Heparin and Carboxymethylchitosan Metal Nanoparticles: An Evaluation of Their Cytotoxicity
A. Bava (2013)
10.1002/bip.21032
Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.
H. Mok (2008)
10.1016/j.jconrel.2010.06.008
Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules.
P. K. Selbo (2010)
10.1016/j.biomaterials.2008.08.004
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.
K. S. Rao (2008)
10.1016/j.jconrel.2009.06.008
A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
H. Hatakeyama (2009)
10.1074/JBC.M108331200
Melittin Enables Efficient Vesicular Escape and Enhanced Nuclear Access of Nonviral Gene Delivery Vectors*
M. Ogris (2001)
10.1016/j.actbio.2010.08.003
Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells.
C. Greulich (2011)
10.1146/ANNUREV.BIOCHEM.67.1.199
The caveolae membrane system.
R. Anderson (1998)
10.1096/fj.02-0088com
Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery
J. Panyam (2002)
10.1042/BJ20021945
Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles.
R. Jones (2003)
10.1016/j.biomaterials.2011.08.048
The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles.
M. Safi (2011)
10.1021/NL052396O
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
10.1038/nnano.2012.237
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
10.1146/ANNUREV.CELLBIO.17.1.517
Biological basket weaving: formation and function of clathrin-coated vesicles.
F. Brodsky (2001)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1126/science.1174621
Lipid Rafts As a Membrane-Organizing Principle
D. Lingwood (2010)
10.2147/IJN.S36111
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
E. Fröhlich (2012)
10.1007/s11051-010-9911-8
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
A. AlKilany (2010)
10.1111/J.1600-0854.2007.00572.X
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
Falk Duchardt (2007)
10.1096/fj.09-129825
Surface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sneha Sundaram (2009)
10.1016/j.cell.2005.12.038
Ligands for Clathrin-Mediated Endocytosis Are Differentially Sorted into Distinct Populations of Early Endosomes
Melike Lakadamyali (2006)
10.1073/pnas.1305804110
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
C. Choi (2013)
10.1002/smll.200901262
Smart magnetic fluorescent nanoparticle imaging probes to monitor microRNAs.
Do Won Hwang (2010)
Clathrin-coated pit-associated proteins are required for alveolar macrophage phagocytosis.
D. G. Perry (1999)
10.1021/nl101140t
Effect of nanoparticle surface charge at the plasma membrane and beyond.
R. Arvizo (2010)
10.1039/B503234B
Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots.
S. Santra (2005)
10.1016/j.cell.2004.08.017
Endocytosis by Random Initiation and Stabilization of Clathrin-Coated Pits
M. Ehrlich (2004)
10.1034/J.1600-0854.2003.00128.X
Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms.
R. Parton (2003)
10.1172/JCI35548
Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.
C. Buono (2009)
10.1021/mp100308n
Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.
Chiranjeevi Peetla (2010)
10.1016/S0378-5173(02)00315-0
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.
S. Prabha (2002)
10.1021/JA0370894
Simultaneous in situ total internal reflectance fluorescence/atomic force microscopy studies of DPPC/dPOPC microdomains in supported planar lipid bilayers.
James E Shaw (2003)
10.1517/17425247.2012.694864
Delivery to mitochondria: a narrower approach for broader therapeutics
S. Malhi (2012)
10.1023/A:1022219003551
Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells
J. Panyam (2004)
10.3109/17435390.2013.773465
Surface functionalization affects the zeta potential, coronal stability and membranolytic activity of polymeric nanoparticles
W. Cho (2014)
10.1016/j.jconrel.2012.09.019
A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape.
F. Salomone (2012)
10.1021/mp700140a
Biophysical characterization of nanoparticle-endothelial model cell membrane interactions.
Chiranjeevi Peetla (2008)
10.1016/S0962-8924(01)02082-7
Clathrin-mediated endocytosis: membrane factors pull the trigger.
K. Takei (2001)
10.1038/nmat2442
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
10.1073/pnas.1019267108
Membrane lipidome of an epithelial cell line
Julio L. Sampaio (2011)
10.1083/jcb.95.2.676
Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts
F. Maxfield (1982)
10.1002/ijc.20405
Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer
S. Sahoo (2004)
10.1021/mp900011h
Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.
Chiranjeevi Peetla (2009)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.1021/bm900266r
Interaction of nanoparticles with cells.
V. Mailaender (2009)
10.1021/bm700535p
Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells.
Oshrat Harush-Frenkel (2008)
10.1038/sj.bjc.6600138
Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy
L. Prasmickaite (2002)
10.1021/nn9012274
Size and dynamics of caveolae studied using nanoparticles in living endothelial cells.
Zhenjia Wang (2009)
10.1073/pnas.1308345110
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Poornima Kolhar (2013)
10.1126/SCIENCE.1083780
Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo
D. Larson (2003)
10.1016/j.jconrel.2010.11.004
Endosomal escape pathways for delivery of biologicals.
Amir K. Varkouhi (2011)
10.1155/2013/875048
Performance of Glutamate Dehydrogenase and Triose Phosphate Isomerase Genes in the Analysis of Genotypic Variability of Isolates of Giardia duodenalis from Livestocks
Natália M N Fava (2013)
10.1002/BIP.20403
Direct Fmoc/tert-Bu solid phase synthesis of octamannosyl polylysine dendrimer-peptide conjugates.
E. Kantchev (2006)
10.1021/JA0645943
Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
I. Slowing (2006)
10.1084/JEM.182.2.389
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products
F. Sallusto (1995)
10.1021/am300840p
Permission to enter cell by shape: nanodisk vs nanosphere.
Yi Zhang (2012)
10.1007/s00424-011-1058-7
Physiology of potassium channels in the inner membrane of mitochondria
I. Szabò (2011)
10.1038/32588
Dendritic cells and the control of immunity
J. Banchereau (1998)
10.1039/C3TB20884B
Poly-l-lysine assisted synthesis of core-shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria.
X. Wang (2013)
10.1021/JA068127X
Electroformation of giant vesicles on a non-electroconductive substrate.
Yukihisa Okumura (2007)
10.1038/NMAT1571
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Oded Rabin (2006)
10.1016/j.taap.2009.09.015
Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro.
H. Johnston (2010)
10.1016/S0169-409X(96)00483-8
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)



This paper is referenced by
10.1016/j.tiv.2018.07.003
Dose-dependent cytotoxicity of bismuth nanoparticles produced by LASiS in a reference mammalian cell line BALB/c 3T3.
Thamile Luciane Reus (2018)
10.3109/10408444.2015.1058747
Nanomaterial translocation–the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs–a review
A. Kermanizadeh (2015)
10.1007/s10354-016-0432-7
Endocytic pathways and endosomal trafficking: a primer
Sarah R Elkin (2016)
10.1039/C6NR06158C
Shape-dependent cellular behaviors and relaxivity of iron oxide-based T1 MRI contrast agents.
Jennifer A. Sherwood (2016)
10.1039/c7nr00364a
Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.
Stefania Corvaglia (2017)
10.1177/2049936117713593
The role of nanotechnology in the treatment of viral infections
Lavanya Singh (2017)
10.1002/chem.201503943
A Three‐Component Assembly Promoted by Boronic Acids Delivers a Modular Fluorophore Platform (BASHY Dyes)†
Fábio Miguel Figueiredo Santos (2016)
10.2147/IJN.S125808
Aggregation is a critical cause of poor transfer into the brain tissue of intravenously administered cationic PAMAM dendrimer nanoparticles
Yoshika Kurokawa (2017)
Diluted concentrations of large (above one hundred nanometer) silver nanoparticles inhibited the growth of different types and origin of cancer cells
Amer T. Tawfeeq عامر طالب توفيق (2014)
10.1155/2019/8483765
PEGylated Polyethylenimine Derivative-Mediated Local Delivery of the shSmad3 Inhibits Intimal Thickening after Vascular Injury
Yu Wang (2019)
10.1016/j.critrevonc.2015.10.015
Nanoparticle-siRNA: A potential cancer therapy?
Samuel Wang Sherng Young (2016)
10.1016/j.jconrel.2019.10.010
Evaluation of polyvinylpyrrolidone and block copolymer micelle encapsulation of serine chlorin e6 and chlorin e4 on their reactivity towards albumin and transferrin and their cell uptake.
Ilche Gjuroski (2019)
10.1080/10408444.2017.1328400
A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials
W. Boyes (2017)
10.3389/fnins.2019.00689
Tissue Response to Neural Implants: The Use of Model Systems Toward New Design Solutions of Implantable Microelectrodes
M. Gulino (2019)
10.1016/j.ijpharm.2018.10.023
Uniformly sized iron oxide nanoparticles for efficient gene delivery to mesenchymal stem cells
Qianhao Xu (2018)
10.1038/s41598-018-31165-3
Live Intracellular Biorthogonal Imaging by Surface Enhanced Raman Spectroscopy using Alkyne-Silver Nanoparticles Clusters
M. Ardini (2018)
10.3390/nano8100761
The Impact of Metallic Nanoparticles on Stem Cell Proliferation and Differentiation
Ahmed Abdal Dayem (2018)
10.1007/s00232-019-00082-5
Direct Drug Targeting into Intracellular Compartments: Issues, Limitations, and Future Outlook
G. I. Harisa (2019)
10.1016/j.colsurfb.2018.05.004
Preparation of well-defined brush-like block copolymers for gene delivery applications under biorelevant reaction conditions.
Joana R. Góis (2018)
10.1007/s10965-018-1654-8
Gelatin-poly (ethylene glycol) methyl ether-functionalized porous Nanosilica for efficient doxorubicin delivery
Uyen Vy Vo (2018)
10.1080/17460441.2020.1750591
Nanonization techniques to overcome poor water-solubility with drugs
Flávia Lidiane Oliveira Da Silva (2020)
10.1016/j.actbio.2020.04.015
Nanotechnology and Immunoengineering: How nanotechnology can boost CAR-T therapy.
Waqas Nawaz (2020)
10.1016/j.msec.2017.04.087
Cellular internalisation kinetics and cytotoxic properties of statistically designed and optimised neo-geometric copper nanocrystals.
K. Murugan (2017)
10.15406/JNMR.2015.02.00030
Effect of Zinc Oxide and Titanium Dioxide Nanoparticles on Supported Lipid Bilayers
Nora Grincevičiūtė (2015)
10.2147/IJN.S148487
Inhibition of cancer cell migration with CuS@ mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression
Guoying Deng (2018)
10.1016/j.omtn.2020.02.011
Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain
T. Kim (2020)
10.1177/0883911520921499
Curcumin-loaded poly-ε-caprolactone nanoparticles show antioxidant and cytoprotective effects in the presence of reactive oxygen species
Del Prado-Audelo M Luisa (2020)
10.1016/j.cca.2018.10.004
Challenges facing nanotoxicology and nanomedicine due to cellular diversity.
M. Akhtar (2018)
Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain
Bin Bostanudin (2016)
10.1109/TNS.2020.2974316
Luminescent Nanocomposites for Biomedical Applications
K. Popovich (2020)
10.5075/epfl-thesis-8844
Development of a nano-adjuvant cancer vaccine and its evaluation for melanoma in combination with radiotherapy
Sylvie Hauert (2018)
10.3109/10717544.2015.1023384
Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells
X. Yang (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar